Features

Features

• How CGM Technology Is Transforming Diabetes Management

  Understanding CGM technology in diabetes management helps patients monitor blood sugar levels in real time, improving control and reducing complications.  Continue Reading

• Understanding the Dangers of Nutraceuticals and Dietary Supplements

  Although these compounds are marketed as health products, a lack of regulation complicates patient safety and comprehensive research on the formulations.  Continue Reading

• 5 Life Sciences Market Entry Strategies in the United States

  LifeSciencesIntelligence expands on previous articles focused on the steps to market entry by highlighting five potential market entry strategies.  Continue Reading

• Innovative Tech for Drug Manufacturing: Revolutionizing Pharma

  Innovative pharmaceutical technology for drug manufacturing enhances drug quality, efficiency, and customization.  Continue Reading

• Exploring Digital Transformations in Life Sciences, Biomedical Affairs

  Exploring digital transformations in life sciences is vital for accelerating drug discovery, improving patient care, and advancing healthcare innovation.  Continue Reading

• Exploring Business Development Strategies for Pharma Startups

  Exploring business development strategies for pharmaceutical startups is vital for innovation, patient care, economic growth, and global health challenges.  Continue Reading

• Exploring the Role of Healthcare Providers in CGM Coaching, Education

  Continuous glucose monitoring (CGM) coaching and education are crucial as they empower patients to make informed decisions.  Continue Reading

• Ensuring Drug Safety Through Regulatory Compliance

  Regulatory compliance ensures drug safety by enforcing standards, preventing harm, and ensuring quality control.  Continue Reading

• The Impact of Biotechnology Breakthroughs in Healthcare

  Biotechnology breakthroughs are crucial in healthcare for revolutionizing treatments and enhancing patient outcomes.  Continue Reading

• A Look at California’s Newest Bans on Chemicals in Food

  The California Food Safety Act bans certain additives in the food supply that the FDA has not prohibited nationwide.  Continue Reading

• 5 Critical Steps for Entering the Life Sciences Market

  As new technologies and advancements continue to add to the life sciences space, companies must have a comprehensive understanding of entering the life sciences market.  Continue Reading

• How to Develop Assays to Measure Biomarkers

  As more clinical research and drug development emphasize the importance of biomarkers, it is critical to develop assays that measure them accurately.  Continue Reading

• 10 Things to Know About the Updated 2023 COVID-19 Vaccines

  Public awareness of the updated COVID-19, RSV, and flu vaccines is vital for informed decisions and protection against new strains.  Continue Reading

• Exploring the Economic Toll of Chronic, Infectious Diseases in the US

  In the United States, chronic and infectious diseases strain healthcare, productivity, and small businesses, costing trillions annually.  Continue Reading

• How Quality Assurance Shapes US Drug Manufacturing

  Quality assurance in US drug manufacturing ensures safe and effective medications, safeguarding patient health.  Continue Reading

• Five Ways That Genetic Research and Advancements Inform Healthcare

  As genetic research advances, healthcare professionals, patients, and other stakeholders must determine how new data and tools will inform care.  Continue Reading

• Revolutionizing Clinical Trial Data Tracking, Analysis with Technology

  Healthcare technology is revolutionizing the tracking and analysis of clinical trial data, boosting efficiency, accuracy, and the discovery of breakthrough treatments.  Continue Reading

• Comparing Chip vs. Animal Models in Medical Research

  Comparing organ-on-a-chip and animal models in research aids ethical, scientific, and practical decisions, enhancing study accuracy and relevance.  Continue Reading

• How Do Various Stakeholders Define Clinically Meaningful Data?

  Understanding how stakeholders define clinically meaningful data can help researchers and investors determine the best pharmaceutical interventions.  Continue Reading

• Can Pharmaceutical Companies Ethically Sponsor Medical Education?

  Although pharmaceutical companies sponsor multiple aspects of medical education, these relationships present a moral gray area.  Continue Reading

• Understanding the Link Between Air Pollution and Respiratory Illnesses

  Understanding the link between air pollution and respiratory illness is vital to protecting public health and reducing preventable disease burdens.  Continue Reading

• Expanding Product Portfolios Through Technology Integration

  Expanding product portfolios through technology integration streamlines diagnostics, telemedicine, and patient care, revolutionizing healthcare processes.  Continue Reading

• Exploring Innovations in Cell Production for Sustainable Healthcare

  Innovations in sustainable cell production improve healthcare equity by enhancing access to therapies, reducing costs, and promoting environmental sustainability.  Continue Reading

• Understanding Implications of Pharmacogenomic on Prescribing

  Pharmacogenomic research can enhance personalized medicine, optimize drug efficacy, improve safety, reduce treatment costs, and inform research and development.  Continue Reading

• 7 Ways to Increase Pharmaceutical Sustainability

  Enhancing pharmaceutical sustainability safeguards the planet's health while ensuring a vital global supply of medications.  Continue Reading

• Exploring 10 Pregnancy Complications, Risk Factors, and Prevention

  Understanding common pregnancy complications and management can help improve public health efforts to reduce maternal mortality rates.  Continue Reading

• Exploring the Challenges and Promises of Fecal Microbiome Transplants

  Fecal microbiome transplants have transitioned from being on the fringes of medicine to the forefront of scientific research and clinical practice.  Continue Reading

• Managing Pediatric Behavioral Health with Pharmacological Treatments

  Children's mental and behavioral health conditions can be challenging to manage; however, pharmaceuticals and other tools are helpful in treatment.  Continue Reading

• Understanding Gaps in Mental Health Treatment Amidst National Crisis

  Exacerbated by the COVID-19 pandemic, disparities in mental health treatment persist domestically and globally.  Continue Reading

• Dissecting Ethical Principles in the Pharmaceutical Industry

  Multiple ethical dilemmas in the pharmaceutical industry impact industry members, providers, and patients.  Continue Reading

• Understanding Pharmaceutical Drug Addiction: Types, Signs, Treatments

  Although attention has focused on the opioid crisis, multiple types of drug addiction require attention from the healthcare system.  Continue Reading

• Exploring 7 Common Autoimmune Diseases, Management Tools

  Despite no cures for autoimmune diseases, researchers are conducting studies to advance treatment and work toward a cure.  Continue Reading

• Understanding HIV Drug Resistance, Minimizing Disease Transmission

  Minimizing HIV transmission requires a multifaceted approach, including understanding HIV drug resistance and its implications.  Continue Reading

• Enhancing Mental Wellness with Psychobiotics, the Gut–Brain Connection

  Psychobiotics benefit human health by positively influencing the gut–brain axis and gut microbiota interactions.  Continue Reading

• Understanding Gaps in Women’s Health: Gynecological Cancer Research

  Research to address ongoing gaps is vital for cancer prevention, improving cancer diagnosis, and minimizing cancer deaths in female patients.  Continue Reading

• Assessing the Expected Impacts of OTC Hormonal Birth Control Pills

  Newly approved OTC hormonal birth control pills are expected to improve contraceptive access, reduce healthcare spending, and save time.  Continue Reading

• What Factors Limit the Adoption and Development of Cell Therapy?

  Despite the lifesaving application of cell therapy, limitations have hindered its widespread adoption.  Continue Reading

• Exploring the 5 FDA-Approved IUDs: Types, Benefits, and Effectiveness

  IUDs are a primary tool to control reproduction, benefit public health, empower individuals, and enhance healthcare outcomes.  Continue Reading

• How Do Nonprofit Pharmaceutical Companies Get Funding?

  Funding nonprofit pharmaceutical companies drives the development of affordable and accessible drugs.  Continue Reading

• Exploring and Comparing Types of Cell Therapy and Its Applications

  As science advances and more cell therapies come to market, it is critical to compare their varying types and applications to determine the best clinical uses.  Continue Reading

• Top 10 Myths About Medicinal and Recreational Cannabis

  Addressing the top 10 myths about medicinal and recreational cannabis promotes accurate information, reduces stigma, and ensures safe and responsible use.  Continue Reading

• Exploring Prevalent Disparities in Gynecological Cancers

  Exploring prevalent disparities in gynecological cancers can illuminate research, screening, and care gaps.  Continue Reading

• Applications of Psilocybin in Mental Health Disorder Treatments

  A recent revolution in psychedelics has caused researchers to explore the applications of psilocybin in mental health disorder treatments.  Continue Reading

• Addressing Disparities in Minority Mental Healthcare: Risk and Access

  America must address disparities in mental health risks and access to care that disproportionately impact racial/ethnic and sexual minority groups.  Continue Reading

• Top 3 Use Cases for Psychedelics, Understanding Ongoing Research

  Ongoing clinical research in psychedelics primarily focuses on 3 prominent use cases: anxiety and depression, PTSD, and substance use disorders.  Continue Reading

• Debunking the 9 Most Common Myths About GMOs

  By dispelling common misconceptions, a more constructive discussion can be had about the health benefits of GMOs.  Continue Reading

• Understanding Food Poisoning, Healthcare Professionals’ Role in Prevention

  Food poisoning poses health risks, burdens the healthcare system, increases costs, and compromises care quality.  Continue Reading

• How Monoclonal Antibodies Are Shaping the Future of Healthcare

  Monoclonal antibodies have unleashed the power of precision medicine for various medical conditions.  Continue Reading

• Exploring the Science of Happiness: How to Lead a Happier Life

  Speakers at the 2023 WMIF discuss a longitudinal study exploring the science of happiness and examining how to lead a happier life.  Continue Reading

• Guiding Obesity Management by Understanding Weight Loss Drugs

  Weight loss drugs can be critical in obesity management; however, nuances and complexities indicate the need for additional guidance.  Continue Reading

• WMIF: FDA Commissioner Discusses Revamping Accelerated Approval

  At the 2023 World Medical Innovation Forum (WMIF), the FDA Commissioner discussed revamping accelerated approval.  Continue Reading

• Biopharmaceutical Leaders Challenge the IRA’s Innovation Implications

  As part of a panel at the WMIF, biopharmaceutical leaders challenged the IRA for its implications on and perceived challenges in innovation.  Continue Reading

• Exploring the Link Between Human Gut Microbiota and Human Health

  Scientific research reveals a profound link between gut microbiota and human health, expanding beyond digestion.  Continue Reading

• Understanding the Basics of Pharmaceutical Compounding

  Pharmaceutical compounding plays a crucial role in addressing individual medication requirements but carries inherent risks.  Continue Reading

• Exploring Biofilms on Medical Devices and Intervention Strategies

  Research sheds light on a hidden threat to the healthcare community and patients: biofilms.  Continue Reading

• Top Challenges Facing Biosimilar Adoption and Manufacturing

  Although biosimilars can decrease prescription drug spending and increase patient access, there are challenges and concerns regarding biosimilar adoption and manufacturing.  Continue Reading

• Understanding Asthma Type, Risk, Prevalence, and Disparities

  Understanding asthma risk factors may help improve treatment options and highlight disparities in asthma prevalence.  Continue Reading

• Exploring the Health Benefits of Adopting a Mediterranean Diet

  Ongoing research and data have explored the health benefits of adopting a Mediterranean diet to control weight, manage chronic disease, and improve overall health.  Continue Reading

• How Medical Affairs Impact the Pharmaceutical Industry

  Despite being crucial for scientific communication between companies and industry leaders, the growing responsibility of medical affairs has contributed to various challenges.  Continue Reading

• The Top 5 Most Expensive FDA-Approved Gene Therapies

  Hemgenix, Skysona, Zynteglo, Zolgensma, and Luxturna comprise the top 5 most expensive gene therapies approved by the FDA.  Continue Reading

• Exploring Virtual Reality Exposure Therapy in Mental Healthcare

  Researchers continue to explore and enhance virtual reality exposure therapy in mental healthcare for treating PTSD, anxiety, OCD, and other mental health conditions.  Continue Reading

• Applying Artificial Intelligence, Machine Learning in Cancer Care

  In addition to the critical role artificial intelligence and machine learning play in the pharmaceutical industry, they have significant implications in advancing cancer detection, treatment, and recovery.  Continue Reading

• Exploring HPV Vaccines, Updated Guidelines, and Preventive Measures

  The fight against HPV and its related health risks relies on key factors to minimize transmission and improve population health.  Continue Reading

• Exploring FDA-Approved Drugs and Potential Treatment Options for ALS

  Researchers are actively exploring a range of FDA-approved drugs and potential treatment options for amyotrophic lateral sclerosis.  Continue Reading

• Comparing Small Molecule and Biologics Drug Development Challenges

  The development process for small molecule drugs and biologics is drastically different, presenting varying challenges for manufacturers, regulatory organizations, healthcare providers, and patients.  Continue Reading

• Strategies for Sustainability in the Global Pharmaceutical Supply Chain

  Sustainable strategies are essential for the global pharmaceutical industry's supply chain to minimize its environmental impact, reduce greenhouse gas emissions, preserve natural resources, and address growing concerns about climate change.  Continue Reading

• Greater Pharmacist Role Improves Pharma Supply Chain Management

  Empowering pharmacists to become more involved in pharma supply chain management gives patients and caregivers a more personalized and proactive approach to care.  Continue Reading

• How to Properly Dispose of Unused Drugs, Understanding Key Roles

  All members of the healthcare system, including manufacturers, providers, and patients, may play a role in properly disposing of unused or expired drugs and medicines.  Continue Reading

• The Impacts of Restricting Comprehensive Reproductive Healthcare

  Many healthcare professionals and respectable organizations have discussed the negative impacts of restricting access to comprehensive reproductive healthcare.  Continue Reading

• FDA Domestic and Foreign Oversight Protocols and Violation Responses

  In light of recent findings from manufacturing inspections, it is critical to understand FDA oversight protocols, violation responses, and potential shortcomings domestically and internationally.  Continue Reading

• A Current Look at Reproductive Health Policy in the United States

  Following the Supreme Court’s decision in Dobbs v. Jackson, reproductive health policy in the United States has evolved rapidly. Here’s a current look at reproductive health in the US.  Continue Reading

• Understanding Good Prescribing Principles and Medication Errors

  Good prescribing principles are critical strategies for minimizing medication errors that may contribute to adverse drug events or patient fatalities.  Continue Reading

• Fundamentals of the Pharmaceutical Supply Chain

  The complex pharmaceutical supply chain poses challenges requiring efficient solutions to deliver vital medications.  Continue Reading

• The Policy Problem Behind Adderall's Pharmaceutical Supply Chain Crisis

  Drugs used to treat ADHD have been lacking for months now, leading to problems with access to prescription amphetamines and creating questions about the cause of the massive shortage.  Continue Reading

• Diabetes in the United States: Examining the National Crisis

  Across the United States, a national crisis has continued to develop as the rates of diabetes rise, exacerbated by environmental and lifestyle factors.  Continue Reading

• Exploring Organ-on-a-Chip Models as an Animal Model Alternative

  In light of the recently passed FDA Modernization Act 2.0, researchers are exploring organ-on-a-chip models as an animal model alternative.  Continue Reading

• A Closer Look at the Most Recent Pfizer Acquisition Deal: Seagen Inc

  Considering the hefty price tag on the most recent Pfizer acquisition deal, pharmaceutical industry leaders may benefit from a closer look at Seagen and why it’s appealing.  Continue Reading

• Exploring Theories on the Cause of Sudden Infant Death Syndrome (SIDS)

  Although no definitive causes of sudden infant death syndrome have been identified, researchers are exploring new theories on the source of the condition.  Continue Reading

• Exploring Traditional, Experimental Screenings for Colorectal Cancer

  Considering the rising rates of colorectal cancer, clinicians are looking at traditional and experimental screening tools for detecting the condition.  Continue Reading

• Regulating and Authorizing Medicines: A Comparison of the FDA and EMA

  Comparing the EMA and FDA pathways for regulating and authorizing medications may explain approval patterns and protocols for new drugs.  Continue Reading

• Exploring Fertility Treatments and Understanding Access Barriers

  Individuals unable to conceive through intercourse may explore fertility treatments; however, access barriers, including cost and location, may prevent them from seeking treatment.  Continue Reading

• How PFAS Chemicals Globally Impact the Environment and Human Health

  Per- and polyfluroralky substances (PFAS), also called forever chemicals, are a growing concern because of their widespread use and adverse human health and environmental impacts.  Continue Reading

• Understanding the Causes of Infertility, Risk Factors, and Diagnosis

  Understanding the underlying causes of infertility, the potential risk factors, and how to diagnose them may help up to 15% of couples in the United States manage and address infertility.  Continue Reading

• Beyond Hot Flashes: Understanding Menopause, Symptoms, and Treatment

  Despite affecting nearly everyone with female reproductive anatomy, very few understand menopause, its symptoms, and treatment beyond hot flashes and menstrual cycle changes.  Continue Reading

• Enhancing the Understanding of Eating Disorders, Treatment Options

  As one of the deadliest and most common mental illnesses in children and young adults, researchers are looking to enhance the understanding of eating disorders and develop treatment options.  Continue Reading

• Developing Clinical Trial Budgets, Considerations, and Best Practices

  Although there are some best practices for developing clinical trial budgets, the many considerations and factors required to create a budget can complicate it.  Continue Reading

• Differentiating Between Postpartum Depression and Baby Blues

  While feelings of sadness and fatigue are common after childbirth, differentiating between baby blues and more serious postpartum depression is critical for delivering adequate care.  Continue Reading

• Effectively Managing Clinical Trials, Recruitment, and Adaptive Trials

  Learning how to effectively manage clinical trials, from recruitment to trial design and adaptability, is critical for the economic well-being of clinical research organizations.  Continue Reading

• Comparing Global Pharmaceutical Markets: US, UK, and China

  While contributing to the more significant global pharmaceutical market, the US, the UK, and China each have unique pharmaceutical markets managed by their respective regulatory organizations.  Continue Reading

• Understanding Crohn’s Disease, Its Symptoms, Diagnosis, and Treatment

  As millions of people globally struggle with Crohn’s disease, understanding the symptoms, diagnostics, and treatment of the condition can help providers improve patient care strategies and outcomes.  Continue Reading

• Alternatives to Animal Testing Models in Clinical and Biomedical Research

  Over the past several years, a growing number of alternative techniques have been developed and used to replace animal testing models in clinical and biomedical research.  Continue Reading

• Understanding the Basics of COVID-19, Acute and Chronic Illness

  Although COVID-19 is a complex viral illness, understanding the basics of infection, acute illness, and its subsequent chronic outcomes can help inform future research, patient care, and prevention strategies.  Continue Reading

• The Fundamentals of Animal Testing in Clinical Research

  Because humans and animals are biologically similar, animal testing in clinical research helps researchers learn how to prevent, treat, and cure human diseases and ensure product safety.  Continue Reading

• Developing and Launching Drugs, Considerations, and Best Practices

  Developing, launching, and marketing drugs can be complex and require multiple considerations by the company, the public, and regulatory agencies; however, following best practices can ensure a profitable and effective launch.  Continue Reading

• Understanding the Impacts of Sexually Transmitted Infections

  Sexually transmitted infections, whether curable or incurable, can have long-term impacts if they are not prevented and treated appropriately.  Continue Reading

• Policy in Practice: How the Influenza Act Would Influence Healthcare

  If approved, the Influenza Act, introduced in December 2022, could influence healthcare practices surrounding seasonal and pandemic influenza.  Continue Reading

• Treating Seasonal Affective Disorder, Understanding Knowledge Gaps

  With 5% of adults in the United States experiencing seasonal affective disorder, understanding available treatments and knowledge is necessary for delivering effective patient care and directing future research.  Continue Reading

• From COVID to Cancer, Understanding the Applications of mRNA Vaccines

  Throughout the COVID-19 pandemic, mRNA vaccines have grown in popularity; however, the applications of mRNA vaccines may expand far past COVID-19, benefiting other infectious diseases, cancers, allergies, and genetic illnesses.  Continue Reading

• Scientists Explore HIV Treatments, Drugs, Vaccines, and Gene Therapy

  With 38.4 million people affected globally, scientists are exploring new HIV treatment and prevention strategies, including new antiretroviral drugs, vaccines, and gene therapies.  Continue Reading

• How the US Farm Bill Contributes to Adverse Human Health Outcomes

  Although the United States Farm Bill was created to maintain a steady supply of food, it has evolved into a policy that now results in numerous adverse human health outcomes.  Continue Reading